LAS VEGAS, June 27, 2022 (GLOBE NEWSWIRE) -- Alkame Holdings, Inc. (OTC PINK: ALKM), a publicly traded diversified holding company, is pleased to announce that its wholly owned subsidiary Bell Food and Beverage, Inc. is preparing to pack its sixth consecutive year of farm to jar blueberries for export to Japan.
July is National Blueberry Month and Bell Food & Beverage Inc. is preparing their facility to manage the influx of hundreds of thousands of pounds of blueberries to arrive directly from farmers within the Pacific Northwest. Bell Food & Beverage will be packing for Pacific Flavors, Intl. once again, and plans to begin the farm to jar bottling production around July 15th. Bell expects to pack at least 250,000 jars for PFI.
“Going from the farm to the jar within twenty-four hours makes it all the more impressive, and really provides our client with the freshest and most flavorful fruit possible for their customers. The quality speaks for itself, and we are very excited to continue to provide the best for Pacific Flavors.”
About Bell Food and Beverage, Inc.
Bell Food and Beverage, Inc., is a wholly owned subsidiary of Alkame Holdings, Inc. and is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and PET bottles and jars.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded diversified holding company. The Company's wholly owned subsidiaries include proprietary water technology with several unique properties, food and beverage manufacturing and co-packing, CBD /Hemp food and beverage manufacturing, and utilizes their enhanced water technology whenever applicable, along with several company owned developed and acquired consumer brands. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications by placement into several emerging business sectors, such as consumer bottled water and RTD products, household pet products, and many other various water-based treatment solutions to both new and existing business platforms. For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
